Skip to main content
logo
Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
10.52
-0.02 (-0.19%)
At close: Oct 28, 2026, 4:00 PM EDT
10.75
+0.23 (2.19%)
Pre-market: Oct 29, 2026, 7:15 AM EDT

Corvus Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
8855753448640112
Market Cap Growth
61.58%67.27%298.31%118.11%-64.73%12.29%
Enterprise Value
67051030256-740
Last Close Price
10.527.705.351.760.852.41

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.939.4010.562.230.711.16
P/TBV Ratio
3.939.4010.562.230.711.16

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.020.030.040.050.04
Net Debt / Equity Ratio
-0.95-0.91-1.56-0.67-0.71-0.68
Net Debt / EBITDA Ratio
3.771.301.851.111.261.74
Net Debt / FCF Ratio
4.741.692.001.081.461.79
Quick Ratio
15.886.091.473.963.997.22
Current Ratio
16.166.211.544.074.067.36
Return on Equity (ROE)
-35.43%-32.60%-174.85%-57.02%-53.90%-51.08%
Return on Assets (ROA)
-21.66%-38.36%-30.09%-25.63%-22.50%-24.61%
Return on Capital Employed (ROCE)
-25.20%-69.60%-82.20%-60.30%-55.60%-38.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-5.94%-2.66%-18.12%-31.32%-104.39%-38.55%
FCF Yield
-5.11%-5.73%-7.40%-27.77%-68.97%-32.73%
Buyback Yield / Dilution
-22.16%-30.76%-26.99%-3.16%-11.23%-41.98%
SEC Filings: 10-K · 10-Q